Skip to main content

Chimerix Inc

CMRXDelisted Apr 21, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001117480

Chimerix Inc was delisted on Apr 21, 2025; its insiders filed their last Form 4 on Apr 21, 2025; 119 institutions reported holding it in 13F filings for Q1 2025, worth $618.1M in total; no superinvestor held it.

Holders of 5% or more of CMRX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Chimerix Inc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Chimerix Inc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Chimerix Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CMRX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 13, 20255:21 PM ETGoldman Sachs Group Incand 1 other13G/A0.00%0 shares−6.00 ppfrom 6.00%Below 5%Jun 30, 2025SEC
May 15, 20254:53 PM ETRa Capital Management, L.P.and 3 others13G/A0.00%0 shares–Below 5%Mar 31, 2025SEC
May 9, 202512:23 PM ETGoldman Sachs Group Incand 1 other13G6.00%5.67M sharesNewMar 31, 2025SEC
Apr 17, 20255:12 PM ETGlazer Capital, LLCand 1 other13G4.92%4.61M sharesNewBelow 5%Apr 10, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Chimerix Inc shares.

No Form 144 notices for Chimerix Inc are on file.